Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis

Aim. The aim of the study is to determine the effectiveness of liver transplantation (LT) in the treatment of unresectable hepatocellular carcinoma (HCC) occurred in normal liver.Material and methods. 6 patients with unresectable HCC underwent orthotopic liver transplantation (OLT). The long-term...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. D. Olisov, M. S. Novruzbekov, I. E. Galankina, L. N. Zimina, V. A. Gulyaev, L. V. Donova, M. Sh. Khubutiya
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-09-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	hepatocellular carcinoma liver transplantation unresectable hepatocellular carcinoma in non-cirrhotic liver anabolic steroids
Online Access:	https://www.gastro-j.ru/jour/article/view/254
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
by: Kazuo Tarao, et al.
Published: (2019-03-01)

Serum chemerin level in patients with liver cirrhosis and primary and multifocal hepatocellular carcinoma with consideration of insulin level
by: Monika Pazgan-Simon, et al.
Published: (2024-10-01)

Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant
by: Zhang S, et al.
Published: (2025-02-01)

Differentiating Liver Metastases from Primary Liver Cancer: A Retrospective Study of Imaging and Pathological Features in Patients with Histopathological Confirmation
by: Laura Andreea Ghenciu, et al.
Published: (2025-01-01)

Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice
by: V. V. Petkau, et al.
Published: (2022-12-01)

A new prognostic model for predicting overall survival and progression-free survival in unresectable hepatocellular carcinoma treated with the FOLFOX-HAIC regimen based on patient clinical characteristics and blood biomarkers
by: Qiuyao Zeng, et al.
Published: (2025-01-01)

Pathology and diagnostic approaches to well-differentiated hepatocellular lesions: a narrative review
by: Joon Hyuk Choi, et al.
Published: (2025-01-01)

Nomogram for predicting early cancer-related death due to recurrence after liver resection in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B/C: a multicenter study
by: Zhan-Cheng Qiu, et al.
Published: (2025-01-01)

Overview of hepatocarcinogenesis focusing on cellular origins of liver cancer stem cells: a narrative review
by: Jong Ryeol Eun
Published: (2025-01-01)

Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years
by: Yeshong Park, et al.
Published: (2024-12-01)

Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
by: I. A. Goncharova, et al.
Published: (2023-03-01)

Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
by: Melchor Alpízar Salazar, et al.
Published: (2025-01-01)

Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
by: Parissa Tabrizian, et al.
Published: (2025-02-01)

Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective study
by: Alizée Renan, et al.
Published: (2025-02-01)

Preoperative assessment of liver regeneration using T1 mapping and the functional liver imaging score derived from Gd-EOB-DTPA-enhanced magnetic resonance for patient with hepatocellular carcinoma after hepatectomy
by: Qian Li, et al.
Published: (2025-01-01)

The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma
by: Wu Y, et al.
Published: (2025-02-01)

Proteomic Characterization of Liver Cancer Cells Treated with Clinical Targeted Drugs for Hepatocellular Carcinoma
by: Hezhou Long, et al.
Published: (2025-01-01)

Comparative Analysis of ChatGPT and Human Expertise in Diagnosing Primary Liver Carcinoma: A Focus on Gross Morphology
by: Prakasit Sa-ngiamwibool, et al.
Published: (2025-02-01)

CHROMOPHOBE HEPATOCELLULAR CARCINOMA: DIAGNOSTIC CHALLENGES
by: Sana Ben-Slama, et al.
Published: (2025-01-01)

Effective and Safe Treatment of Risky Localized Liver Tumors Using Microwave Ablation in Patients with Comorbid Lung Diseases Unfit for Deep Anesthesia
by: Murat ASIK
Published: (2024-03-01)

Structure of Patients with Hepatocellular Cancer (Data Analysis from Two Specialised Centres)
by: M. V. Mayevskaya, et al.
Published: (2020-05-01)

Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis
by: Lingling Zhao, et al.
Published: (2025-02-01)

A novel ubiquitination-related gene signature for overall survival prediction in patients with liver hepatocellular carcinoma
by: Xiuyun Chen, et al.
Published: (2025-01-01)

The role of artificial intelligence and image processing in the diagnosis, treatment, and prognosis of liver cancer: a narrative-review
by: Platon Dimopoulos, et al.
Published: (2024-09-01)

Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma
by: V. V. Petkau, et al.
Published: (2023-11-01)

Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
by: Finn RS, et al.
Published: (2025-02-01)

Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression
by: Liqin Ruan, et al.
Published: (2025-02-01)

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01)

Screening and Early Diagnosis of Hepatocellular Cancer and Optimization of Diagnostic Imaging Techniques: A Review and Conclusion of the Expert Panel
by: V. V. Breder, et al.
Published: (2023-02-01)

Risk factors of development of hepatocellular carcinoma
by: V. T. Ivashkin, et al.
Published: (2009-02-01)

3D synergistic tumor-liver analysis further improves the efficacy prediction in hepatocellular carcinoma: a multi-center study
by: Yurong Jiang, et al.
Published: (2025-01-01)

Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan
by: Jaekyung Cheon, et al.
Published: (2025-01-01)

Machine Learning-based Prediction of HBV-related Hepatocellular Carcinoma and Detection of Key Candidate Biomarkers
by: Zeynep KUCUKAKCALI, et al.
Published: (2022-09-01)

Chronic alcohol intoxication and liver diseases
by: A. I. Khazanov, et al.
Published: (2009-02-01)

Helicobacter pylori Infection and Hepatobiliary Pathology
by: S. V. German, et al.
Published: (2018-09-01)

Diagnosis of hepatocellular carcinoma using liquid biopsy-based biomarkers: a systematic review and network meta-analysis
by: Yutong Jiang, et al.
Published: (2025-01-01)

Deep learning-based CT radiomics predicts prognosis of unresectable hepatocellular carcinoma treated with TACE-HAIC combined with PD-1 inhibitors and tyrosine kinase inhibitors
by: Linan Yin, et al.
Published: (2025-01-01)

Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts
by: Simona Parisse, et al.
Published: (2025-01-01)

The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection
by: Yu ZC, et al.
Published: (2025-01-01)

Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
by: Lingzhan Meng, et al.
Published: (2024-11-01)